MENU
+Compare
LXRX
Stock ticker: NASDAQ
AS OF
Sep 16 closing price
Price
$1.10
Change
-$0.02 (-1.79%)
Capitalization
399.74M

LXRX Lexicon Pharmaceuticals Forecast, Technical & Fundamental Analysis

Lexicon Pharmaceuticals Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LXRX with price predictions
Sep 16, 2025

LXRX in +6.48% Uptrend, growing for three consecutive days on September 12, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LXRX advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where LXRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LXRX as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LXRX turned negative on August 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

LXRX moved below its 50-day moving average on September 15, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LXRX crossed bearishly below the 50-day moving average on September 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LXRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LXRX broke above its upper Bollinger Band on August 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LXRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.088) is normal, around the industry mean (20.607). P/E Ratio (0.000) is within average values for comparable stocks, (53.283). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.160). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (6.821) is also within normal values, averaging (333.412).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LXRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LXRX is expected to report earnings to fall 750.00% to -6 cents per share on October 30

Lexicon Pharmaceuticals LXRX Stock Earnings Reports
Q3'25
Est.
$-0.06
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.02
The last earnings report on August 06 showed earnings per share of 0 cents, beating the estimate of -9 cents. With 1.46M shares outstanding, the current market capitalization sits at 399.74M.
A.I. Advisor
published General Information

General Information

a company, which engages in discovery and development of breakthrough treatments for human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2445 Technology Forest Boulevard
Phone
+1 281 863-3000
Employees
285
Web
https://www.lexpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTEQX15.460.12
+0.78%
Templeton Emerging Markets Small Cap R6
OAZGX37.310.09
+0.24%
Oakmark Global R6
ESPCX32.83N/A
N/A
Allspring Special Small Cap Value C
CGVVX15.32N/A
N/A
Causeway Global Value Inv
BRBMF0.76N/A
N/A
Big Rock Brewery Inc.

LXRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with PLRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
-1.79%
PLRX - LXRX
39%
Loosely correlated
N/A
VCYT - LXRX
37%
Loosely correlated
+1.29%
OCUL - LXRX
36%
Loosely correlated
-0.84%
EPIX - LXRX
34%
Loosely correlated
+0.52%
AMRN - LXRX
33%
Loosely correlated
N/A
More